FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to pharmacology and clinical pharmacology, specifically to a novel use of bis(N-allylimidazole)zinc diacetate of formula
or bis(N-allyl-2-methylimidazole)zinc diacetate of formula
,
where Ac is acetate, Me is methyl, as a wound healing agent. Also disclosed is an agent for external wound healing.
EFFECT: reduced time of wound healing and tissue regeneration without scar formation.
4 cl, 12 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPLEX ZINC COMPOUND WITH N-ISOPROPENYLIMIDAZOLE AS A WOUND-HEALING AGENT | 2019 |
|
RU2725634C1 |
ZINC ACETATE COMPLEX WITH 3-HYDROXYPYRIDINE WITH ANTI-HYPOXIC ACTIVITY UNDER CONDITIONS OF ACUTE EXOGENOUS HYPOXIA | 2016 |
|
RU2631496C1 |
COMPLEX OF ZINC ACETATE WITH 1-PROPARGYLIMIDAZOL WITH ANTI-HYPOXIC ACTIVITY | 2016 |
|
RU2632682C1 |
COMBINED COMPOSITION FOR TREATING INFECTED WOUNDS OF VARIOUS ORIGINS | 2018 |
|
RU2691144C1 |
AGENT FOR HEALING CUTANEOUS WOUND BY PRIMARY TENSION | 2004 |
|
RU2270007C2 |
METHOD FOR TREATING WOUNDS | 2020 |
|
RU2758243C1 |
WOUND HEALING PRODUCT IN THE FORM OF AN OINTMENT CONTAINING RUBIDIUM CHLORIDE | 2019 |
|
RU2722127C1 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES OF SOFT TISSUES AND MUCOUS MEMBRANES | 2010 |
|
RU2445083C1 |
ANTIBACTERIAL AND WOUND-HEALING AGENT "ULTRAKOL" | 2002 |
|
RU2220724C1 |
PHARMACEUTICAL SUBSTANCE FOR TREATING INFECTED WOUNDS OF VARIOUS ORIGINS | 2018 |
|
RU2697869C1 |
Authors
Dates
2020-04-17—Published
2019-10-04—Filed